Paclitaxel Injection, Powder, Lyophilized, For Suspension
Product Images NDC 0781-3531

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Paclitaxel (NDC 0781-3531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Reconstitution (Paclitaxel 01)

An illustration showing a vial connected to a syringe needle by a tube or line, depicting preparation or administration of a medication.*

FDA Label Image

Structure (Paclitaxel 02)

Chemical structure diagram of paclitaxel, showing its molecular framework with various functional groups including aromatic rings, hydroxyl, acetyl, and benzoyl groups arranged on a complex multi-ring backbone.*

FDA Label Image

Vial Label (Paclitaxel 03)

Label for Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) 100 mg per vial, a lyophilized powder for intravenous injection. The single-dose vial is labeled for use by Sandoz Inc. The label includes storage instructions, dosage warnings, and manufacturer information from Jiangsu Hengrui Pharmaceuticals Co., Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.